TY - JOUR
AU - Konieczny, Marek J
AU - Omarov, Murad
AU - Zhang, Lanyue
AU - Malik, Rainer
AU - Richardson, Tom G
AU - Baumeister, Sebastian-Edgar
AU - Bernhagen, Jürgen
AU - Dichgans, Martin
AU - Georgakis, Marios K
TI - The genomic architecture of circulating cytokine levels points to drug targets for immune-related diseases.
JO - Communications biology
VL - 8
IS - 1
SN - 2399-3642
CY - London
PB - Springer Nature
M1 - DZNE-2025-00123
SP - 34
PY - 2025
AB - Circulating cytokines orchestrate immune reactions and are promising drug targets for immune-mediated and inflammatory diseases. Exploring the genetic architecture of circulating cytokine levels could yield key insights into causal mediators of human disease. Here, we performed genome-wide association studies (GWAS) for 40 circulating cytokines in meta-analyses of 74,783 individuals. We detected 359 significant associations between cytokine levels and variants in 169 independent loci, including 150 trans- and 19 cis-acting loci. Integration with transcriptomic data point to key regulatory mechanisms, such as the buffering function of the Atypical Chemokine Receptor 1 (ACKR1) acting as scavenger for multiple chemokines and the role of tumor necrosis factor receptor-associated factor 1 (TRAFD1) in modulating the cytokine storm triggered by TNF signaling. Applying Mendelian randomization (MR), we detected a network of complex cytokine interconnections with TNF-b, VEGF, and IL-1ra exhibiting pleiotropic downstream effects on multiple cytokines. Drug target cis-MR using 2 independent proteomics datasets paired with colocalization revealed G-CSF/CSF-3 and CXCL9/MIG as potential causal mediators of asthma and Crohn's disease, respectively, but also a potentially protective role of TNF-b in multiple sclerosis. Our results provide an overview of the genetic architecture of circulating cytokines and could guide the development of targeted immunotherapies.
KW - Humans
KW - Cytokines: blood
KW - Cytokines: genetics
KW - Cytokines: metabolism
KW - Genome-Wide Association Study
KW - Immune System Diseases: genetics
KW - Immune System Diseases: drug therapy
KW - Immune System Diseases: blood
KW - Immune System Diseases: immunology
KW - Mendelian Randomization Analysis
KW - Polymorphism, Single Nucleotide
KW - Genomics: methods
KW - Genetic Predisposition to Disease
KW - Cytokines (NLM Chemicals)
LB - PUB:(DE-HGF)16
C6 - pmid:39794498
C2 - pmc:PMC11724035
DO - DOI:10.1038/s42003-025-07453-w
UR - https://pub.dzne.de/record/275888
ER -